MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2024 International Congress

September 27-October 1, 2024. Philadelphia, PA.

View by Title View Sessions
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • EEG dominant frequency as a potential biomarker of cognition in Lewy body diseases.

    R. Heo, J. Wallner, N. Mukhopadhyay, D. Krusienski, M. Barrett (Richmond, USA)

  • EEG Profiles in People with Functional Movement Disorders Before and After a Single Bout of Hatha Yoga and Moderate-vigorous Intensity Aerobic Exercise: A Protocol for a Pilot Feasibility Study

    D. Kipnis, P. Smith, S. Leung, M. Bjalme-Evan, A. Nesru, C. Amlang, H. Shah, K. Froud, L. Quinn (New York, USA)

  • Effect of bilateral internal segment of the globus pallidus deep brain stimulation on acquired multifocal dystonia due to natural gas intoxication.

    A. Luque-Ambrosiani, D. Macías-García, F. Carrillo, L. Muñoz-Delgado, S. Jesús, A. Adarmes-Gómez, E. Ojeda-Lepe, Y. Chocrón-González, M. Oliver-Romero, P. Mir (Seville, Spain)

  • Effect Of Botulinum Toxin On Non-Motor Symptoms In Adult-Onset Idiopathic Focal Dystonia

    S. Mehta, R. Gupta, N. Balaini, S. Grover, V. Lal (Chandigarh, India)

  • Effect of Diabetes Mellitus on the Phenotype of Parkinson’s Disease

    IH. Kwak, HI. Ma, YE. Kim, JJ. Lee (Anyang-si, Republic of Korea)

  • Effect of Ecopipam, a Selective Dopamine-1 Receptor Antagonist, on Tic Characteristics as Assessed by the YGTSS: Results from a Phase IIb Randomized, Double-blind, Placebo-controlled Clinical Trial in Tourette Syndrome

    D. Gilbert, G. Karkanias, S. Atkinson, F. Munschauer, S. Wanaski, T. Cunniff (Cincinnati, USA)

  • Effect of Istradefylline on Motor and Non-motor Symptoms in Patients with Parkinson’s Disease: the ISTRA ADJUST PD Randomized, Controlled Study

    H. Nagayama, T. Hatano, R. Sengoku, N. Yanagisawa, O. Kano (Tokyo, Japan)

  • Effect of Levodopa therapy in Hypokinetic Dysarthria in Parkinson’s Disease

    E. Smaoui, N. Farhat, S. Daoud, K. Moalla, N. Bouattour, M. Damak, C. Mhiri (Sfax, Tunisia)

  • Effect of Opicapone and Levodopa on Daily Motor Patterns in Parkinson’s Disease Patients with Early Motor Fluctuations: Findings from the Korean ADOPTION Study

    J. Lee, J. Ferreira, H. Ma, J. Rocha, B. Jeon (Seoul, Republic of Korea)

  • Effect of Opicapone and Levodopa on the Different Daily OFF Patterns in Patients with Parkinson’s Disease and Early Motor Fluctuations: Findings from the Korean ADOPTION Study

    J. Lee, J. Ferreira, H. Ma, J. Rocha, B. Jeon (Seoul, Republic of Korea)

  • « Previous Page
  • 1
  • …
  • 60
  • 61
  • 62
  • 63
  • 64
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Survey-Based study of marijuana used in Parkinson’s Disease patients
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Life expectancy with and without Parkinson’s disease in the general population
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley